secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2022-06-13T23:59:59+00:00
Accession:  0001104659-22-070355
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconova promotes Guerin to COO/CFO, Makovski Silverstein to head corp dev; Oler resigns
--------------------------------------------------------------------------------

- Mark Guerin appointed COO/CFO; salary raised to $475K; receives 50,250 options and 16,500 RSUs.
- Dr. Adar Makovski Silverstein promoted to Senior Director and Head of Corporate Development.
- Avi Oler, SVP Corporate Development and General Counsel, resigns effective June 17, 2022.
- Guerin's equity awards vest over three years: RSUs 33/33/34%, options 1/3 at year 1 then monthly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465922070355/0001104659-22-070355-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465922070355/tm2218255d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-070355

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer